A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.
Acs Medicinal Chemistry Letters
Weïwer, Michel M; Spoonamore, James J; Wei, Jingqiang J; Guichard, Boris B; Ross, Nathan T NT; Masson, Kristina K; Silkworth, Whitney W; Dandapani, Sivaraman S; Palmer, Michelle M; Scherer, Christina A CA; Stern, Andrew M AM; Schreiber, Stuart L SL; Munoz, Benito B